rDEN4σ30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers

Anna P. Durbin, Stephen S. Whitehead, Julie McArthur, John R. Perreault, Joseph E. Blaney, Bhavin Thumar, Brian R. Murphy, Ruth A. Karron

Research output: Contribution to journal › Article › peer-review

108 Scopus citations

Fingerprint

Dive into the research topics of 'rDEN4σ30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers'. Together they form a unique fingerprint.

Medicine & Life Sciences